<--- Back to Details
First PageDocument Content
Bavituximab / Docetaxel / Non-small-cell lung carcinoma / Lung cancer / Cyclacel / Cancer vaccine / Chemistry / Organic chemistry / Medicine
Date: 2014-04-24 16:59:47
Bavituximab
Docetaxel
Non-small-cell lung carcinoma
Lung cancer
Cyclacel
Cancer vaccine
Chemistry
Organic chemistry
Medicine

April, 2014 Powerful science. Novel therapies. Dedicated to patients. About Peregrine Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trial

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

Download Document from Web Archive

File Size: 880,16 KB